NeuBase Therapeutics, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
NeuBase Therapeutics, Inc. had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of $741.46 thousand as of 2019-07-12, per its 10-K filed 2020-12-23.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet · last filed 2020-12-23
- 2019-07-12: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $741.46K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net |
|---|---|
| 2019-07-12 | $741.46K 10-K · filed 2020-12-23 |